As premiums soar, lawmakers clash over who should control rates
May 14, 2025
Louisiana opens grant applications for Recreational Trail Projects statewide
May 15, 2025
Thibodaux Regional Health System is proud to announce it is the first hospital in the region to offer a first-of-its-kind treatment option for carotid artery disease (CAD). The Neuroguard IEP® System is a new FDA-approved medical device designed to reduce the chance of stroke during and after the procedure to treat CAD.
CAD is caused by the narrowing of the carotid arteries on either side of the neck that carry blood to the brain. CAD is responsible for up to a third of all strokes. People with high levels of LDL cholesterol, high blood pressure, diabetes, and a history of smoking may be at greater risk for this condition.
The Neuroguard IEP® System is a 3-in-1 stenting system physicians use to restore blood flow that is restricted due to CAD. During the procedure, a stent is placed in the carotid artery to keep blood flowing. A small balloon is then inflated to help the stent stay in place against the artery walls. A filter helps trap tiny blood clots called emboli that may be released during the procedure and can cause stroke. Most people return home from the hospital the day after the procedure.
“It is an honor and a privilege to be able to offer patients in our community a minimally invasive treatment option for stroke prevention and for treating carotid artery disease,” said Dr. Chad Dugas, Interventional Cardiologist with Thibodaux Regional Cardiology Clinic. “I am especially thrilled to provide treatment with the Contego Neuroguard IEP system which has demonstrated increased procedure efficiency and superior safety outcomes.”
